| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25903fe151af1b917696212dc2e59e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_288aff3439ce8668fd705984ad4d2001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_737619f033de6b3541075253f25d27f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55116e0df42ff06147541c22a20b9ab0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69726a2d5019ea6faa093015016f67aa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2004-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6715322d59037df580ee6edcd03d65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5705bd8daff15073a4c0ec0906101e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ccafb25f6878c9094730880493c2f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d4b31d3f3e0496d8425bf525453071f |
| publicationDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006001728-A1 |
| titleOfInvention |
Peptide substance restoring myocardium function |
| abstract |
The invention refers to the pharmaceutical substances intended for the treatment of cardiovascular diseases and can be used as a substance restoring myocardium function in the course of treatment of different forms of this pathology. There is proposed a new tetrapeptide alanyl-glutamyl-aspartyl-arginine with general formula: Ala-Glu-Asp-Arg sequence 1 [SEQ ID NO:1], revealing biological activity, which is manifested in the restoration of the myocardium function. There is proposed a pharmacological substance containing an effective amount of tetrapeptide alanyl-glutamyl-aspartyl-arginine with general formula: Ala-Glu-Asp-Arg sequence 1 [SEQ ID NO: I] as a peptide agent, revealing biological activity, which is manifested in the restoration of myocardium function. Being included in the medication, this substance contributes to the restoration of the myocardium function. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071556-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007139431-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101289220-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8057810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009105157-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8524674-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7851449-B2 |
| priorityDate |
2004-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |